July 14th - 15th, 2015101 Avenue of the Americas, New York, NY, United States
Engineering Biology for Science & Industry: Accelerating Progress
Follow up meeting to discuss next steps and initiate serious planning to develop the thoughts and ideas discussed in April.
Topics of discussion will include the identification of some large pools of federal funding ($50 to $170 million over five years) that present potential opportunities for support, additional programs that can support policy development, public engagement as well as ethical and security issues. Lastly, we will begin some road mapping activities during the meeting.
Director, Science & Technology Innovation Progam
Nancy J Kelley
President & CEO
Nancy J Kelley & Associates
Woodrow Wilson Center
Perry Fellow in International Security
CISAC, Stanford University
NYU Langone Medical Center
Helena Rubinstein Chair
Founder and Chief Scientist
Tracy Lessor, PhD, MBA, ELS
Senior Leader, Science Communications
Feinstein Kean Healthcare
BioBuilder Educational Foundation
Karen Ingram & Associates
Vice President of Content Strategy
O'Reilly Media, Inc.
Head of Research and Vice President
Novartis Influenza Vaccines
Head of Structural Biology
Imperial College London
Product Marketing Manager
New England Biolabs
Virginia CornishColumbia University
Spencer AdlerBioeconomy Capital
Eleonore PauwelsWilson Center
Gilonne d'OrignyNew Harvest
Matt MaranoGen9 Inc.
Mike LoukidesO'Reilly Media
David RejeskiWilson Center
PETER WEIGELENew England Biolabs
Philip DormitzerNovartis Influenza Vaccines
Dave WhelanNancy J Kelley + Associates
Breton HornblowerNew England Biolabs
Jef BoekeNYU Langone Medical Center
Karen IngramKaren Ingram & Associates, Inc.
New York Genome Center, 101 Avenue of the Americas, New York, NY, United States